Literature DB >> 20722042

Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis.

Winfried Häuser1, Maria Kosseva, Nurcan Üceyler, Petra Klose, Claudia Sommer.   

Abstract

OBJECTIVE: To systematically assess the potential association of fibromyalgia syndrome (FMS) with emotional, physical, and sexual abuse.
METHODS: The databases EMBase, Google Scholar, Medline, and PsycINFO (through April 2010) and the reference sections of original studies were searched for eligible studies. Eligible studies were cohort or case--control studies that assessed at least one type of emotional, physical, or sexual abuse in childhood or adulthood in patients with FMS and in controls. Two authors independently extracted descriptive, quality, and outcome data from included studies. Methodologic quality was assessed by the Newcastle-Ottawa Quality Assessment Scale. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were pooled across studies by using the random-effects model. Heterogeneity was assessed by I(2) statistics.
RESULTS: The search identified 18 eligible case-control studies with 13,095 subjects. There were significant associations between FMS and self-reported physical abuse in childhood (OR 2.49 [95% CI 1.81-3.42], I(2) = 0%; 9 studies) and adulthood (OR 3.07 [95% CI 1.01-9.39], I(2) = 79%; 3 studies), and sexual abuse in childhood (OR 1.94 [95% CI 1.36-2.75], I(2) = 20%; 10 studies) and adulthood (OR 2.24 [95% CI 1.07-4.70], I(2) = 64%; 4 studies). Study quality was mostly poor. Low study quality was associated with higher effect sizes for sexual abuse in childhood, but not with other effect sizes.
CONCLUSION: The association of FMS with physical and sexual abuse could be confirmed, but is confounded by study quality.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 20722042     DOI: 10.1002/acr.20328

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  57 in total

1.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  Clinical Profiles of Young Adults With Juvenile-Onset Fibromyalgia With and Without a History of Trauma.

Authors:  Sarah Nelson; Natoshia Cunningham; James Peugh; Anjana Jagpal; Leslie M Arnold; Anne Lynch-Jordan; Susmita Kashikar-Zuck
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

Review 3.  Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Authors:  Brian Walitt; Gerard Urrútia; María Betina Nishishinya; Sarah E Cantrell; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

4.  [Stress-induced hyperalgesia].

Authors:  W Häuser; K Bernardy
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

5.  Association of abuse history with symptom severity and quality of life in patients with fibromyalgia.

Authors:  Juan Jiao; Ann Vincent; Stephen S Cha; Connie A Luedtke; Terry H Oh
Journal:  Rheumatol Int       Date:  2014-08-18       Impact factor: 2.631

Review 6.  Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.

Authors:  Sheena Derry; Philip J Wiffen; Winfried Häuser; Martin Mücke; Thomas Rudolf Tölle; Rae F Bell; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-03-27

7.  Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients.

Authors:  Winfried Häuser; Eva-Maria Hoffmann; Frederick Wolfe; Angus B Worthing; Neil Stahl; Russell Rothenberg; Brian Walitt
Journal:  Clin Exp Rheumatol       Date:  2015-03-18       Impact factor: 4.473

8.  [Prevalence of chronic pain in Germany. A representative survey of the general population].

Authors:  W Häuser; G Schmutzer; A Hinz; A Hilbert; E Brähler
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

9.  You get used to it, or do you: symptom length predicts less fibromyalgia physical impairment, but only for those with above-average self-efficacy.

Authors:  Charles Van Liew; Gabriel Leon; Mikayla Neese; Terry A Cronan
Journal:  Psychol Health Med       Date:  2018-09-30       Impact factor: 2.423

10.  The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample.

Authors:  Randy Neblett; Howard Cohen; YunHee Choi; Meredith M Hartzell; Mark Williams; Tom G Mayer; Robert J Gatchel
Journal:  J Pain       Date:  2013-03-13       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.